Bronchiectasis trials in Poland
6 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleThe AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- Where
- Bialystok, Chorzów, Piaseczno, Rzeszów, Warsaw, Wołomin
- Age
- 12 years and over
- People
- 1,755 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06872892 · EU 2024-518589-29-00 - Phase 3Not yet taking people in PolandA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
- Where
- Bialystok, Chorzów, Piaseczno, Rzeszów, Świdnik, Warsaw, Wroclaw
- Age
- 12 years and over
- People
- 1,500 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07915219 · EU 2026-527086-30-00 - No phaseTaking peopleLong-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
- Where
- Krakow, Lodz, Poznan
- Age
- 18 years and over
- People
- 468 worldwide
- Run by
- Physio-Assist
See details and how to joinNCT06487273 - Phase 1Taking peopleA Two-part study to learn the amount of polymyxin E1 in the body over time formed after a single inhaled dose of colistimethate sodium (CMS) in healthy adults (Part 1) and after single inhaled and vein-infused doses of CMS in adults with non‑cystic fibrosis bronchiectasis (NCFB) (Part 2)
- Where
- Bialystok, Jozefow
- Age
- 18 years and over
- People
- 55 worldwide
- Run by
- Zambon S.p.A.
See details and how to join2025-524324-22-00 - Phase 2Taking peopleDose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Where
- Białystok, Bydgoszcz, Katowice, Krakow, Ostrowiec Świętokrzyski, Piaseczno, Sosnowiec, Szczecin
- Age
- 18 years to 85 years
- People
- 180 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07048262 · EU 2024-518821-13-00 - Phase 2Taking peopleA Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
- Where
- Bialystok, Ksawerów, Piaseczno, Rzeszcow, Sosnowiec
- Age
- 18 years to 85 years
- People
- 363 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07201051 · EU 2025-522892-27-00